Jaguar Health Files Definitive Proxy Statement

Ticker: JAGX · Form: DEF 14A · Filed: Feb 24, 2025 · CIK: 1585608

Jaguar Health, INC. DEF 14A Filing Summary
FieldDetail
CompanyJaguar Health, INC. (JAGX)
Form TypeDEF 14A
Filed DateFeb 24, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, annual-meeting, regulatory-filing

TL;DR

Jaguar Health filed its proxy statement for the annual meeting - vote your shares!

AI Summary

Jaguar Health, Inc. filed a definitive proxy statement (DEF 14A) on February 24, 2025, for its annual meeting of stockholders. The filing concerns the solicitation of proxies for the meeting, which will include the election of directors and other corporate matters. The company is headquartered at 200 Pine Street, Suite 400, San Francisco, CA.

Why It Matters

This filing is crucial for shareholders as it outlines the agenda for the annual meeting, including director elections and key company proposals, allowing them to make informed voting decisions.

Risk Assessment

Risk Level: low — This is a routine regulatory filing for a public company's annual meeting and does not contain new financial or operational risks.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of a DEF 14A filing?

A DEF 14A filing, or definitive proxy statement, is used by companies to solicit proxies from shareholders for an upcoming meeting, providing details on matters to be voted upon, such as director elections and corporate proposals.

When was this definitive proxy statement filed by Jaguar Health, Inc.?

Jaguar Health, Inc. filed this definitive proxy statement on February 24, 2025.

What is the company's primary business address listed in the filing?

The company's business address is 200 Pine Street, Suite 400, San Francisco, CA 94104.

What is the SEC file number for Jaguar Health, Inc.?

The SEC file number for Jaguar Health, Inc. is 001-36714.

What was Jaguar Health, Inc. formerly known as?

Jaguar Health, Inc. was formerly known as Jaguar Animal Health, Inc., with a date of name change on August 30, 2013.

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on February 24, 2025 regarding Jaguar Health, Inc. (JAGX).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing